Green Cross, Chong Kun Dang show brisk sales in second quarter

Published: 2011-07-06 06:58:00

Updated: 2011-07-06 06:58:00

Green Cross Corp. became the third-biggest drug manufacturer in Korea in terms of quarterly revenue, while Chong Kung Dang Pharmaceutical is expected to see its sales further rise in the second quarter, High Investment Securities said Monday.

Green Cross posted revenues of 185.4 billion won in the second quarter, while Dong-A Pharmaceutical topped sales with 230.9 billion won.

Chong Kun ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.